ID ATX3_RAT Reviewed; 355 AA. AC O35815; DT 28-FEB-2003, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1998, sequence version 1. DT 24-JAN-2024, entry version 158. DE RecName: Full=Ataxin-3; DE EC=3.4.19.12; DE AltName: Full=Machado-Joseph disease protein 1 homolog; GN Name=Atxn3; Synonyms=Mjd, Sca3; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Brain, and Testis; RX PubMed=10732811; DOI=10.1007/s100480050015; RA Schmitt I., Brattig T., Gossen M., Riess O.; RT "Characterization of the rat spinocerebellar ataxia type 3 gene."; RL Neurogenetics 1:103-112(1997). RN [2] RP CATALYTIC ACTIVITY, MUTAGENESIS OF CYS-14; HIS-119 AND ASN-134, AND RP FUNCTION. RX PubMed=17696782; DOI=10.1515/bc.2007.107; RA Tzvetkov N., Breuer P.; RT "Josephin domain-containing proteins from a variety of species are active RT de-ubiquitination enzymes."; RL Biol. Chem. 388:973-978(2007). RN [3] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). RN [4] RP 3D-STRUCTURE MODELING. RX PubMed=12486728; DOI=10.1002/prot.10280; RA Albrecht M., Hoffmann D., Evert B.O., Schmitt I., Wuellner U., Lengauer T.; RT "Structural modeling of ataxin-3 reveals distant homology to adaptins."; RL Proteins 50:355-370(2003). CC -!- FUNCTION: Deubiquitinating enzyme involved in protein homeostasis CC maintenance, transcription, cytoskeleton regulation, myogenesis and CC degradation of misfolded chaperone substrates (PubMed:17696782). Binds CC long polyubiquitin chains and trims them, while it has weak or no CC activity against chains of 4 or less ubiquitins (By similarity). CC Involved in degradation of misfolded chaperone substrates via its CC interaction with STUB1/CHIP: recruited to monoubiquitinated STUB1/CHIP, CC and restricts the length of ubiquitin chain attached to STUB1/CHIP CC substrates and preventing further chain extension (By similarity). CC Interacts with key regulators of transcription and represses CC transcription: acts as a histone-binding protein that regulates CC transcription (By similarity). Acts as a negative regulator of mTORC1 CC signaling in response to amino acid deprivation by mediating CC deubiquitination of RHEB, thereby promoting RHEB inactivation by the CC TSC-TBC complex (By similarity). Regulates autophagy via the CC deubiquitination of 'Lys-402' of BECN1 leading to the stabilization of CC BECN1 (By similarity). {ECO:0000250|UniProtKB:P54252, CC ECO:0000250|UniProtKB:Q9CVD2, ECO:0000269|PubMed:17696782}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide CC and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76- CC residue protein attached to proteins as an intracellular targeting CC signal).; EC=3.4.19.12; Evidence={ECO:0000269|PubMed:17696782}; CC -!- SUBUNIT: Interacts with STUB1/CHIP (when monoubiquitinated) (By CC similarity). Interacts with DNA repair proteins RAD23A and RAD23B. CC Interacts with BECN1 (via its poly-Gln domain) (By similarity). CC Interacts with PRKN, UBR2, VCP and tubulin (By similarity). CC {ECO:0000250|UniProtKB:P54252, ECO:0000250|UniProtKB:Q9CVD2}. CC -!- SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000250|UniProtKB:P54252}. CC Nucleus {ECO:0000250|UniProtKB:P54252}. Lysosome membrane CC {ECO:0000250|UniProtKB:P54252}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P54252}. Note=Predominantly nuclear, but not CC exclusively, inner nuclear matrix. Recruited to lysosomal membrane in CC response to amino acid deprivation by the RagA/RRAGA-RagB/RRAGB CC complex. {ECO:0000250|UniProtKB:P54252}. CC -!- TISSUE SPECIFICITY: Ubiquitously expressed (PubMed:10732811). CC {ECO:0000269|PubMed:10732811}. CC -!- DOMAIN: The UIM domains bind ubiquitin and interact with various E3 CC ubiquitin-protein ligase, such as STUB1/CHIP (By similarity). They are CC essential to limit the length of ubiquitin chains (By similarity). CC {ECO:0000250|UniProtKB:Q9CVD2}. CC -!- PTM: Monoubiquitinated by UBE2W, possibly leading to activate the CC deubiquitinating enzyme activity (By similarity). CC {ECO:0000250|UniProtKB:P54252}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Y12319; CAA72986.1; -; mRNA. DR RefSeq; NP_067734.1; NM_021702.1. DR AlphaFoldDB; O35815; -. DR BMRB; O35815; -. DR SMR; O35815; -. DR BioGRID; 248780; 2. DR STRING; 10116.ENSRNOP00000007505; -. DR MEROPS; C86.001; -. DR iPTMnet; O35815; -. DR PhosphoSitePlus; O35815; -. DR jPOST; O35815; -. DR PaxDb; 10116-ENSRNOP00000007505; -. DR Ensembl; ENSRNOT00000007505.3; ENSRNOP00000007505.1; ENSRNOG00000005470.3. DR Ensembl; ENSRNOT00055024976; ENSRNOP00055020411; ENSRNOG00055014517. DR Ensembl; ENSRNOT00060007983; ENSRNOP00060005977; ENSRNOG00060004720. DR Ensembl; ENSRNOT00065025136; ENSRNOP00065019676; ENSRNOG00065015145. DR GeneID; 60331; -. DR KEGG; rno:60331; -. DR UCSC; RGD:621567; rat. DR AGR; RGD:621567; -. DR CTD; 4287; -. DR RGD; 621567; Atxn3. DR eggNOG; KOG2935; Eukaryota. DR GeneTree; ENSGT00390000001830; -. DR HOGENOM; CLU_031228_1_0_1; -. DR InParanoid; O35815; -. DR OrthoDB; 337428at2759; -. DR PhylomeDB; O35815; -. DR TreeFam; TF314228; -. DR Reactome; R-RNO-5689877; Josephin domain DUBs. DR Reactome; R-RNO-9615017; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes. DR PRO; PR:O35815; -. DR Proteomes; UP000002494; Chromosome 6. DR Bgee; ENSRNOG00000005470; Expressed in testis and 19 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; ISO:RGD. DR GO; GO:0005829; C:cytosol; ISS:ParkinsonsUK-UCL. DR GO; GO:0005765; C:lysosomal membrane; ISS:UniProtKB. DR GO; GO:0005759; C:mitochondrial matrix; ISO:RGD. DR GO; GO:0031966; C:mitochondrial membrane; ISO:RGD. DR GO; GO:0042405; C:nuclear inclusion body; ISO:RGD. DR GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell. DR GO; GO:0005634; C:nucleus; ISO:RGD. DR GO; GO:0051117; F:ATPase binding; ISS:ParkinsonsUK-UCL. DR GO; GO:0004843; F:cysteine-type deubiquitinase activity; ISS:UniProtKB. DR GO; GO:0042826; F:histone deacetylase binding; IPI:RGD. DR GO; GO:0042802; F:identical protein binding; ISS:ParkinsonsUK-UCL. DR GO; GO:1990380; F:K48-linked deubiquitinase activity; ISS:ParkinsonsUK-UCL. DR GO; GO:0061578; F:K63-linked deubiquitinase activity; ISS:ParkinsonsUK-UCL. DR GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:RGD. DR GO; GO:0001222; F:transcription corepressor binding; IPI:RGD. DR GO; GO:0031625; F:ubiquitin protein ligase binding; ISS:UniProtKB. DR GO; GO:0030036; P:actin cytoskeleton organization; ISS:ParkinsonsUK-UCL. DR GO; GO:0034198; P:cellular response to amino acid starvation; ISS:UniProtKB. DR GO; GO:0034605; P:cellular response to heat; ISO:RGD. DR GO; GO:0071218; P:cellular response to misfolded protein; ISS:UniProtKB. DR GO; GO:0006338; P:chromatin remodeling; IEA:GOC. DR GO; GO:0035640; P:exploration behavior; ISO:RGD. DR GO; GO:0045104; P:intermediate filament cytoskeleton organization; ISS:ParkinsonsUK-UCL. DR GO; GO:0000226; P:microtubule cytoskeleton organization; ISS:ParkinsonsUK-UCL. DR GO; GO:0035520; P:monoubiquitinated protein deubiquitination; ISS:UniProtKB. DR GO; GO:1904262; P:negative regulation of TORC1 signaling; ISS:UniProtKB. DR GO; GO:1904294; P:positive regulation of ERAD pathway; ISO:RGD. DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB. DR GO; GO:0071108; P:protein K48-linked deubiquitination; ISS:ParkinsonsUK-UCL. DR GO; GO:0070536; P:protein K63-linked deubiquitination; ISS:ParkinsonsUK-UCL. DR GO; GO:1904379; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; ISO:RGD. DR GO; GO:0036211; P:protein modification process; IDA:RGD. DR GO; GO:0006515; P:protein quality control for misfolded or incompletely synthesized proteins; ISS:UniProtKB. DR GO; GO:0010810; P:regulation of cell-substrate adhesion; ISS:ParkinsonsUK-UCL. DR GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISO:RGD. DR Gene3D; 3.90.70.40; -; 1. DR Gene3D; 1.10.287.10; S15/NS1, RNA-binding; 1. DR InterPro; IPR033865; Ataxin-3. DR InterPro; IPR006155; Josephin. DR InterPro; IPR003903; UIM_dom. DR PANTHER; PTHR14159; ATAXIN-3-RELATED; 1. DR PANTHER; PTHR14159:SF0; ATAXIN-3-RELATED; 1. DR Pfam; PF02099; Josephin; 1. DR Pfam; PF16619; SUIM_assoc; 1. DR Pfam; PF02809; UIM; 3. DR PRINTS; PR01233; JOSEPHIN. DR SMART; SM01246; Josephin; 1. DR SMART; SM00726; UIM; 3. DR PROSITE; PS50957; JOSEPHIN; 1. DR PROSITE; PS50330; UIM; 2. DR Genevisible; O35815; RN. PE 1: Evidence at protein level; KW Hydrolase; Isopeptide bond; Lysosome; Membrane; Nucleus; Phosphoprotein; KW Protease; Reference proteome; Repeat; Thiol protease; Transcription; KW Transcription regulation; Ubl conjugation; Ubl conjugation pathway. FT CHAIN 1..355 FT /note="Ataxin-3" FT /id="PRO_0000053833" FT DOMAIN 1..180 FT /note="Josephin" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00331" FT DOMAIN 224..243 FT /note="UIM 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT DOMAIN 244..263 FT /note="UIM 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT DOMAIN 329..348 FT /note="UIM 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT REGION 257..333 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 257..276 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 277..297 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 309..328 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 14 FT /note="Nucleophile" FT /evidence="ECO:0000250|UniProtKB:P54252" FT ACT_SITE 119 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00331" FT ACT_SITE 134 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00331" FT MOD_RES 268 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9CVD2" FT MOD_RES 272 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9CVD2" FT MOD_RES 273 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9CVD2" FT MOD_RES 321 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9CVD2" FT CROSSLNK 1 FT /note="Peptide (Met-Gly) (interchain with G-Cter in FT ubiquitin)" FT /evidence="ECO:0000250" FT CROSSLNK 200 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in ubiquitin)" FT /evidence="ECO:0000250|UniProtKB:P54252" FT MUTAGEN 14 FT /note="C->A,S: Loss of enzyme activity." FT /evidence="ECO:0000269|PubMed:17696782" FT MUTAGEN 119 FT /note="H->A: Loss of enzyme activity." FT /evidence="ECO:0000269|PubMed:17696782" FT MUTAGEN 134 FT /note="N->A: Loss of enzyme activity." FT /evidence="ECO:0000269|PubMed:17696782" SQ SEQUENCE 355 AA; 40446 MW; 87B6A6EE54FF29F5 CRC64; MESIFHEKQE GSLCAQHCLN NLLQGEYFSP VELSSIAHQL DEEERLRMAE GGVTSEDYRT FLQQPSGNMD DSGFFSIQVI SNALKVWGLE LILFNSPEYQ RLRIDPINER SFICNYKEHW FTVRKLGKQW FNLNSLLTGP ELISDTYLAL FLAQLQQEGY SIFVVKGDLP DCEADQLLQM IKVQQMHRPK LIGEELAHLK EQSALKADLE RVLEAADGPG MFDDDEDDLQ RALAMSRQEI DMEDEEADLR RAIQLSMQGS SRGMCEDSPQ TSSTDLSSEE LRKRREAYFE KQQHQQQEAD RPGYLSYPCE RPTTSSGGLR SNQAGNAMSE EDVLRATVTV SLETAKDSLK AERKK //